DefinePK

Abstract

The Indian pharmaceutical industry plays a crucial global role by providing affordable, high-quality generic medicines and vaccines, particularly through initiatives like the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP). This study investigates the awareness, accessibility, and acceptance of Jan Aushadhi Medicines among patients, exploring how well the PMBJP has addressed India's need for affordable healthcare. Using an exploratory, descriptive research design and informal interviews with a sample of Jan Aushadhi consumers and non-consumers, the study reveals that while general awareness of generic medicines is relatively high, knowledge of Jan Aushadhi products remains limited. Only 40% of respondents were aware of Jan Aushadhi Medicines, with fewer possessing a comprehensive understanding. Accessibility issues and stock shortages further challenge the program's impact, as does a strong doctor preference for prescribing branded medicines.
The findings highlight that increased visibility, targeted outreach, and enhanced availability of Jan Aushadhi Kendras could significantly improve access to affordable medications. Recommendations include expanding awareness campaigns, partnering with state-level hospitals, encouraging doctors to prescribe generics, and implementing effective inventory management to reduce stock shortages. By improving public confidence in Jan Aushadhi products and fostering a supportive ecosystem, the program can better meet its objective of reducing healthcare costs, particularly for economically disadvantaged populations. This study underscores the potential of Jan Aushadhi to make healthcare more affordable but calls for concerted efforts to overcome barriers to its widespread adoption